27789936 28473877 33662390 33989670 29113792 28671996 30078764 32138146 28782506 30452595 27537685 29144506 31186733 35205923 31401765 31653972 33848005 35118070 32094231 33491671 - Search Results

Year	Number of Results
2016	2
2017	5
2018	3
2019	3
2020	2
2021	6
2022	2
2023	0

1

Management of noninfectious posterior uveitis with intravitreal drug therapy.

Tan HY, Agarwal A, Lee CS, Chhablani J, Gupta V, Khatri M, Nirmal J, Pavesio C, Agrawal R. Tan HY, et al. Clin Ophthalmol. 2016 Oct 13;10:1983-2020. doi: 10.2147/OPTH.S89341. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27789936 Free PMC article. Review.

2

Involvement of Nrf2 in Ocular Diseases.

Batliwala S, Xavier C, Liu Y, Wu H, Pang IH. Batliwala S, et al. Oxid Med Cell Longev. 2017;2017:1703810. doi: 10.1155/2017/1703810. Epub 2017 Mar 27. Oxid Med Cell Longev. 2017. PMID: 28473877 Free PMC article. Review.

3

New insights into oxidative stress and immune mechanisms involved in age-related macular degeneration tackled by novel therapies.

Potilinski MC, Tate PS, Lorenc VE, Gallo JE. Potilinski MC, et al. Neuropharmacology. 2021 May 1;188:108513. doi: 10.1016/j.neuropharm.2021.108513. Epub 2021 Mar 1. Neuropharmacology. 2021. PMID: 33662390 Review.

4

The role of the inflammasomes in the pathogenesis of uveitis.

Xu Q, Zhang J, Qin T, Bao J, Dong H, Zhou X, Hou S, Mao L. Xu Q, et al. Exp Eye Res. 2021 Jul;208:108618. doi: 10.1016/j.exer.2021.108618. Epub 2021 May 11. Exp Eye Res. 2021. PMID: 33989670 Review.

5

Transcription factors: Time to deliver.

Ulasov AV, Rosenkranz AA, Sobolev AS. Ulasov AV, et al. J Control Release. 2018 Jan 10;269:24-35. doi: 10.1016/j.jconrel.2017.11.004. Epub 2017 Nov 4. J Control Release. 2018. PMID: 29113792 Review.

6

Photoreceptor oxidative stress in hyperoxia-induced proliferative retinopathy accelerates rd8 degeneration.

Lajko M, Cardona HJ, Taylor JM, Farrow KN, Fawzi AA. Lajko M, et al. PLoS One. 2017 Jul 3;12(7):e0180384. doi: 10.1371/journal.pone.0180384. eCollection 2017. PLoS One. 2017. PMID: 28671996 Free PMC article.

7

A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration.

Santiago CP, Keuthan CJ, Boye SL, Boye SE, Imam AA, Ash JD. Santiago CP, et al. Mol Ther. 2018 Oct 3;26(10):2407-2417. doi: 10.1016/j.ymthe.2018.07.016. Epub 2018 Jul 19. Mol Ther. 2018. PMID: 30078764 Free PMC article.

8

Cell Penetrating Peptides, Novel Vectors for Gene Therapy.

Taylor RE, Zahid M. Taylor RE, et al. Pharmaceutics. 2020 Mar 3;12(3):225. doi: 10.3390/pharmaceutics12030225. Pharmaceutics. 2020. PMID: 32138146 Free PMC article. Review.

9

An inducible form of Nrf2 confers enhanced protection against acute oxidative stresses in RPE cells.

Vu KT, Hulleman JD. Vu KT, et al. Exp Eye Res. 2017 Nov;164:31-36. doi: 10.1016/j.exer.2017.08.001. Epub 2017 Aug 4. Exp Eye Res. 2017. PMID: 28782506 Free PMC article.

10

Clinically Relevant Outcome Measures for the I307N Rhodopsin Mouse: A Model of Inducible Autosomal Dominant Retinitis Pigmentosa.

Massengill MT, Young B, Patel D, Jafri F, Sabogal E, Ash N, Li H, Ildefonso CJ, Lewin AS. Massengill MT, et al. Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5417-5430. doi: 10.1167/iovs.18-25345. Invest Ophthalmol Vis Sci. 2018. PMID: 30452595 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results